Introduction
Freshwater ecosystems are continually exposed to anthropogenic stressors including urban and sub-urban development, climate change, and point (e.g, WWTP effluent) and non-point source pollution (e.g., overland flow, septic leakage; Halpern et al., 2008; Hughes et al., 2013) . Globally, only a fraction of freshwater ecosystems remain relatively pristine (Palmer et al., 2009; Vörösmarty et al., 2010) . Multiple studies have demonstrated how alterations in biodiversity and community structure influence ecosystem dynamics (e.g., Tilman et al., 1997; Hooper and Vitousek, 1997; Downing and Leibold, 2002; Steiner et al., 2005) . However, many of these studies assessed relatively pristine ecosystems, despite their rare occurrence. Anthropogenic stressors have the potential to profoundly alter both ecosystem dynamics and community structure (Jonsson et al., 2002; Relyea, 2005; Muñoz et al., 2009; McMahon et al., 2012; Liess et al., 2013; Dolciotti et al., 2014) . Therefore, further research is needed to quantify how common anthropogenic stressors influence biodiversity and ecosystem dynamics (Relyea and Hoverman, 2006; Clements and Rohr, 2009; Rosi-Marshall and Royer, 2012) .
A wide range of pollutants regularly enter surface waters (Murray et al., 2010) . Previous studies have identified the source, fate and effects of many pollutants, including pesticides (Relyea, 2005) , industrial compounds (Runck, 2007) , heavy metals (Clements et al., 2013) and nutrients (Bernot et al., 2006 ), yet little is known about pharmaceuticals (Halling-Sørensen et al., 1998; Larsson et al., 1999; Rosi-Marshall and Royer, 2012) . Unlike other pollutants, pharmaceuticals are biologically active and elicit responses from organisms across taxonomic groups (Brun et al., 2006) . Pharmaceutical compounds are frequently detected in urban and agriculturally dominated ecosystems due to both human and veterinary uses and subsequent movement into aquatic environments (Veach and Bernot, 2011; Bunch and Bernot, 2011; Hughes et al., 2013) . Currently, studies that focus on the influence of pharmaceuticals on ecosystems are needed (Rosi-Marshall and Royer, 2012; Hughes et al., 2013) .
Frequently detected pharmaceutical pollutants span a number of different chemical classes, including painkillers, psychiatric drugs and antibiotics and are detected across environmental matrices inclusive of water, sediment and organismal tissue (e.g., Kolpin et al., 2002; Du et al., 2012; Gelsleichter and Szabo, 2013; Hughes et al., 2013) . The psychiatric drug carbamazepine is one of the most frequently detected pharmaceutical compounds in freshwater ecosystems of North America, Europe and Asia. Carbamazepine is an anti-epilepsy drug, which is also used to treat bipolar disorder, depression and addiction (Neppe et al., 1988) . Carbamazepine reduces the firing of neurons by blocking sodium channels (Porter and Meldrum, 2012) . Concentrations of carbamazepine sampled from freshwaters worldwide range from 0.5 ng/L to 11,561 ng/L across rivers, streams, and lakes (e.g., Loos et al., 2009; Ferguson et al., 2013; Bernot et al., 2013) with a detection frequency of 85% among study sites (Hughes et al., 2013) . Removal of carbamazepine through abiotic and biotic degradation pathways is minimal in natural ecosystems (5-26%; Miao et al., 2005) . Thus, carbamazepine is considered recalcitrant in freshwater ecosystems (half-life 82 d; Lam et al., 2004) . With high usage rates (1014 tons per year; Zhang et al., 2008) and limited removal, urbanized freshwater ecosystems are persistently exposed to this pollutant.
Carbamazepine is not lethal to freshwater organisms at environmentally relevant concentrations (LC50 N 4 mg/L in Lumbriculus variegatus and Chironomus riparius; Nentwig et al., 2004) . However, chronic effects from exposure to carbamazepine at environmentally relevant concentrations include altered behavior, reduced immune response, and changes in growth and fecundity (Quinn et al., 2008; Gust et al., 2013; Brandão et al., 2013; Lamichhane et al., 2013) . For example, Martin-Diaz et al. (2009) determined that environmentally relevant concentrations of carbamazepine reduced cyclic AMP (cAMP) levels and protein kinase A (PKA) activities in Mytilus galloprovincialis (Mediterranean mussel). Though many studies have demonstrated that carbamazepine poses little acute risk to freshwater organisms, laboratory estimates of toxicity may underestimate the sensitivity of freshwater organisms in natural settings (Buchwalter et al., 2007; Clements et al., 2013) . Freshwater organisms may experience sub-lethal effects, such as changes in behavior, mating success, immuno-competence and development. These sub-lethal effects could alter community structure and diversity of freshwater ecosystems (Bernot and Turner, 2001 ). Therefore, more information is needed to determine how carbamazepine influences freshwater community structure and ecosystem dynamics (Hughes et al., 2013) .
The objectives of this study were to determine how environmentally relevant concentrations of carbamazepine influence the invertebrate community and freshwater ecosystem dynamics. We hypothesized that carbamazepine would reduce the diversity of freshwater invertebrates and change the invertebrate community, which would alter ecosystem characteristics such as primary production, decomposition and dissolved nutrient concentrations ( Fig. 1 ).
Materials and methods

Experimental design
A mesocosm experiment was conducted to quantify the effects of carbamazepine on freshwater invertebrate biodiversity and ecosystem dynamics. Mesocosms (75 L HDPE circular containers; 56.5 cm height; 56.5 cm diameter) were maintained at a Ball State University field station (Hults farm) located in Albany, Indiana (40°18′12″N, 85°13′52″W). Each mesocosm contained 41.5 L of well water (physicochemical characteristics, N = 31: pH 8.2 ± 0.09; dissolved oxygen 6.5 ± 0.7 mg/L; temperature 25.6 ± 0.92°C; nitrate (NO 3 ) 0.15 ± 0.21 mg/L; phosphate (PO 4 ) 43.1 ± 57.5 μg/L), which was added 27 d prior to the introduction of organisms to allow for environmental equilibration. Mesocosms were covered with a fiberglass screen (mesh size: 1 mm) and were exposed to natural elements and light cycles from 8 June 2013 to 11 July 2013 as they were incubated in situ for 31 d following completion of experimental set-up. Each mesocosm received one of four treatments (water and methanol controls and carbamazepine treatments of 200 and 2000 ng/L) with four replicates each (N = 16 total mesocosms). Because carbamazepine treatments used methanol as a solvent, both water and methanol controls were employed to ensure any effects observed could be attributed to carbamazepine as opposed to methanol. Treatment concentrations were selected to represent environmentally-relevant concentrations previously measured in central Indiana freshwaters (Veach and Bernot, 2011; Bernot et al., 2013; Ferguson et al., 2013) .
Mesocosm substrates
Mesh bags (mesh size: 1 mm; dimensions: 14 × 10 cm) containing 20 g of leaf litter were added to each mesocosm to provide nutrition and refuge. Leaf litter was collected from a local pond (40°20′12″N, 85°13′41″W) then dried and weighed prior to addition to mesh bags. Additionally, homogenized sediment collected from a local pond (40°20′12″N, 85°13′41″W) was equally distributed among mesocosms (~300 cm 3 of sediment per mesocosm). Both the leaf litter and sediment were added to each mesocosm 27 d prior to introduction of organisms.
Experimental treatments
Carbamazepine treatments reflected environmentally relevant concentrations measured in surface waters (Loos et al., 2009; Hughes et al., 2013; Ferguson et al., 2013) at 200 and 2000 ng/L in addition to water and methanol controls. Carbamazepine (5H-dibenz[b,f]azepine-5-carboxamide; CAS no 298-46-4) and methanol (HPLC grade) were obtained from Sigma-Aldrich (Milwaukee, WI). A stock solution of 2 mg/mL was prepared by dissolving 0.5 g of carbamazepine in 250 mL of pure methanol (N 99%), as pure carbamazepine is insoluble in water (17.7 mg/L; Syracuse Physprop Database, 2003). Working solutions for each mesocosm were prepared by diluting the stock standard solution with existing water in each experimental unit (i.e., mesocosm) so that the total volume in each mesocosm was b0.1% standard stock solution (0.664 mL). Nominal concentrations of carbamazepine were added to 8 randomly selected mesocosms as a single dose 48 h after the introduction of organisms. Sample collection started 2 d following the addition of carbamazepine stock solution. Pure methanol (12.7 mg/L) was added to 4 randomly selected mesocosms as methanol controls, which resulted in the total volume of these mesocosms being b0.1% methanol (0.664 mL), consistent with carbamazepine treatments. Water controls (N = 4) contained 41.5 L of well water only. At the termination of the experiment, filtered water was collected from each mesocosm for verification of nominal concentrations (see Bernot et al., 2013 for method details) and final carbamazepine concentrations varied b5% relative to target nominal concentrations. Specifically, carbamazepine concentrations were measured using a quantitative procedure incorporating solid phase extraction, separation on a liquid chromatograph, and both positive and negative electrospray ionization with a tandem mass spectrometer to detect transition masses (see Cahill et al., 2004; Furlong et al., 2008) .
Organisms
All organisms were introduced into the mesocosm 27 d following well water introduction and allowed to incubate in situ for experimental duration. Because organisms were collected from local freshwaters, they may have previously had some exposure to carbamazepine. Zooplankton and algae were collected and homogenized from a local pond (40°20′12″N, 85°13′41″W) and were introduced into the mesocosms immediately after collection and homogenization. Diverse aliquots of zooplankton (consisting of calanoid and cyclopoid copepods, ostracods, Scapholeberis sp., Pleuroxus sp., Alona sp., Daphnia pulex, Chydorus sp., Ceriodaphnia sp. and Chaoborus) were evenly distributed among mesocosms. Aliquots (20 mL) of algae (Spirogyra sp.) were also equally distributed among mesocosms.
Four snail species, Lymnaea stagnalis, Physa acuta, Helisoma trivolvis and Elimia livescens (hereafter referred to by generic name), were collected from a local pond (40°0′26″N, 86°7′21″W) and the White River (40°11′8″N, 86°26′21″W) on 6 June 2013 and were acclimated to laboratory conditions for 48 h prior to introduction to mesocosms. Gastropods were added to each mesocosm on 8 June 2013 after measurements of length was collected to determine biomass. These gastropod taxa are common to central Indiana and are important to North American freshwater ecosystems (Wojdak, 2005; Pyron et al., 2008) . To ensure equal biomass across mesocosm treatments at the experiment start, the number of individuals added to each mesocosm varied from 3 to 5 individuals per species due to differences in average body size between individuals (Physa, Lymnaea and Helisoma biomass~30 mg for each taxa per mesocosm and Elimia biomass~350 mg per mesocosm.).
Determination of biotic response to carbamazepine
To quantify the effects of carbamazepine on gastropod biomass, richness and abundance, water was pumped from each mesocosm with the use of a diaphragm pump and drained through a sieve (mesh size: 1 mm) at the end of the experiment. The contents from the sieve were combed through for 3 min for collection of gastropods. Snails were preserved in 10% buffered formalin. All snails were counted and the shell length for each individual was measured. Length measurements were converted to dry mass of fleshy tissue using species-specific lengthweight regressions derived locally (Benke et al., 1999) . Two measurements of biomass were calculated for gastropods, (1) change in biomass and (2) standing biomass. The change in biomass was the average loss or gain (unique to each taxon) of gastropod biomass over the course of the experiment per mesocosm. Total snail biomass change was calculated as the biomass of all live and dead snails (with the latter being collected shells without soft tissue) at experiment end minus the initial biomass of snails. The standing biomass was calculated as only the snails living at the end of the experiment (Wojdak, 2005) . Shannon diversity (H) was calculated for the gastropod community for each mesocosm with the following equation:
where: p i is the proportion of individuals belonging to the ith species.
To determine the influence of carbamazepine on zooplankton richness, abundance, and community structure, samples were collected weeks 1, 3 and 5 post-organism introduction from each mesocosm using a PVC pipe (diameter: 10 cm, height 60 cm) that was arbitrarily placed upright in each mesocosm to ensure that an equal area was sampled with 3 swipes of a dip net (mesh size: 20 μm). Two samples were collected from each mesocosm during individual sampling events. The samples were homogenized and preserved with 90% ethanol. Zooplankton identity was determined with the use of Pennak's freshwater invertebrates of the United States (Smith, 2001) and abundance was quantified using a zooplankton counting wheel and a dissecting microscope. Shannon diversity (H) was also calculated for the zooplankton and the total invertebrate communities (i.e., gastropod and zooplankton) for each mesocosm.
Grab water samples (50 mL) were collected from just below the water surface of each mesocosm to determine the effects of carbamazepine on phytoplankton biomass estimated as the chlorophyll a pigment concentration. These samples were collected weekly throughout the duration of the experiment. Each water sample was transported to the laboratory on ice, filtered immediately onto a glass fiber filter (pore size: 0.7 μm) and frozen until subsequent analysis. Chlorophyll a concentrations of samples were determined via hot ethanol extraction under dim lighting conditions (APHA, 2012). The frozen samples were thawed and submerged in 10 mL of 95% ethanol in a 60 mL falcon tube. The falcon tubes were placed in a water bath of 79°C for 5 min. The samples were then covered in foil to eliminate light exposure and extracted for 24 h in a refrigerator. The absorbance of the supernatant was measured with a spectrophotometer (UV-1700 PharmaSpec, Shimadzu) at 645, 665 and 750 nm. The chlorophyll a concentration was then calculated per standard methods (APHA, 2012) .
Additionally, at the end of the experiment, the leaf litter bags were collected from each mesocosm for measurement of mass. Attached algae were also collected from each mesocosm after the water was removed from the experimental units with a diaphragm pump. Both the algal samples and leaf litter bags were subsequently dried and weighed to determine the dry biomass of each.
Determination of abiotic response to carbamazepine
Weekly grab samples of water were collected just below the surface of the water to measure fluctuations in dissolved nutrient concentrations among mesocosms. Dissolved nutrient concentrations were measured from 20 mL filtered water samples (Whatman glass fiber filter; pore size = 0.7 μm). Nutrient samples were frozen within 24 h of collection until subsequent analyses. Water samples were analyzed by ion chromatography (DIONEX-ICS-3000) using standard protocols (APHA, 2012) to quantify nitrate (NO 3 ), phosphate (PO 4 3 ), fluoride, chloride, bromide, sulfate (SO 4 ) and ammonium (NH 4 ) concentrations. Additionally, dissolved oxygen (DO), pH and temperature were measured twice weekly in each mesocosm.
At the end of the experiment, homogenized sediment samples were collected to determine differences in sediment ash free dry mass (AFDM) among mesocosm treatments. To calculate ash free dry mass, a sediment sub-sample was dried (60°C), weighed, combusted at 500°C and re-weighed in the laboratory. Percent organic matter of homogenized sediment samples was calculated for each mesocosm as the difference in ash and dry weight divided by dry weight (APHA, 2012).
Statistical analyses
The effects of carbamazepine on invertebrate community structure was determined by first ordinating the communities using non-metric multidimensional scaling (nMDS), and then using multiresponse permutation procedures (MRPP) to determine if differences existed among mesocosms exposed to different concentrations for carbamazepine. We used the vegan package in R 3.0.2 (R Development Core Team, 2013) to conduct the nMDS analysis using Bray-Curtis dissimilarities. Data were also analyzed for the effects of carbamazepine on zooplankton and gastropod diversity as well as biotic and abiotic characteristics using Kruskal-Wallis tests, due to non-normal distribution of data. After determining that there were no differences between water and methanol controls, these treatments were combined for future analyses. The linear relationships from these analyses informed an a priori model for testing the influence of carbamazepine on freshwater communities using structural equation modeling (SEM; McMahon et al., 2012) guided by a conceptual model. The SEM was evaluated using the model chisquare and associated P value. These structural equation modeling and Kruskal-Wallis tests were performed using IBM SPSS 21.0 and SPSS Amos statistical software. Alpha was set to 0.05 for all analyses.
Results
Physiochemical characteristics
Temperature (mean = 26.43 ± 3.22°C), pH (mean = 8.44 ± 0.31) and dissolved oxygen (DO; mean = 6.0 ± 0.89 mg/L) varied b2% across mesocosms, but did not differ among treatments (Table 1) . Over the experiment duration, temperature increased from 25.3°C in week 1 to 32.3°C in week 5 across all mesocosms consistent with the growing season.
Carbamazepine effects on pond communities
Ordination of the invertebrate communities using nMDS resulted in a 2-dimensional solution with stress = 0.136 (Fig. 1) . The communities exposed to 2000 ng/L were separated in a distinct cluster different from the communities in other treatments. The MRPP analysis resulted in an overall within-group agreement of A = 0.13 and a significance of 0.04 which lead us to reject the null hypothesis that all communities were the same.
Invertebrate richness increased over the course of the experiment, due to increases in zooplankton richness over time (r = 0.71, P b 0.01). Invertebrate richness was 20% higher in the carbamazepine treatments (mean = 3.58 taxa per mesocosm) compared to the water control (mean = 2.83 taxa per mesocosm; Table 2 ). However, environmentally-relevant concentrations of carbamazepine did not influence invertebrate richness (data not shown, P N 0.05). Invertebrate diversity also increased throughout the experiment and in the carbamazepine treatments (Fig. 2) . Shannon diversity of the invertebrate community was 16% higher in the 2000 ng/L carbamazepine treatment (mean diversity = 1.8 per mesocosm) compared to that of the controls (mean = 1.5 taxa per mesocosm; P = 0.05).
Overall, the total gastropod biomass per mesocosm decreased over the course of the experiment. However, there was no significant difference in total gastropod biomass change between the carbamazepine treatments and controls (data not shown; P = 0.258). Biomass changes in the presence of carbamazepine were dependent on each gastropod taxon. Specifically, Physa, Lymnaea and Elimia lost and Helisoma gained biomass over the course of the experiment, regardless of the carbamazepine treatment (Fig. 3) . However, carbamazepine did not change the biomass of Physa, Lymnaea or Helisoma (P N 0.05) but did influence the Elimia biomass (P = 0.043; Fig. 3 ). The loss of biomass in Elimia was 100% lower in the carbamazepine treatments (mean = −144.76 mg dry mass/31 d) compared to that in controls (mean = −303.8 mg dry mass/31 d).
Carbamazepine did not affect the standing biomass of the total gastropod community (i.e., living biomass of all gastropods in mesocosms; P = 0.718). The effect of carbamazepine on standing biomass was also unique to each gastropod taxon. Overall, Physa, Lymnaea and Elimia gained and Helisoma lost standing biomass over the course of the experiment in the carbamazepine treatments. However, there were no significant differences in standing biomass between the carbamazepine treatments and controls for any of the gastropod taxa (P N 0.05; Table 3 ).
Copepod and ostracod abundance increased in the presence of carbamazepine and cladoceran abundance decreased in the carbamazepine treatments (Fig. 4) . However, there was no significant difference in the abundance of copepods, ostracods or cladocerans between the carbamazepine treatments and controls (data not shown; P = 0.51, 0.271 and 0.241 respectively). However, the abundances of D. pulex, Chydorus and Ceriodaphnia were N 66% lower in the carbamazepine treatments (mean = 4.5, 7.8 and 2 individuals per mesocosm, respectively) compared to the controls (mean = 10.5, 13 and 21.67 individuals per mesocosm). However, carbamazepine did not influence the abundances of Chydorus or Ceriodaphnia at environmentally relevant concentrations (P N 0.05). The abundance of D. pulex was higher in the controls than in the 200 ng/L carbamazepine treatment (P = 0.5). Despite variations in primary producers, carbamazepine did not influence algal mass or phytoplankton biomass found in mesocosms (P = 0.718 and 0.318 respectively; Fig. 5 ). However, the sediment organic matter was N 29% lower in the carbamazepine treatments (mean = 4.31%) compared to that in the controls (mean = 5.56%; P b 0.04; Fig. 5 ).
CBZ (ng/L)
Fluoride, bromide, chloride, nitrate (NO 3 ), phosphate (PO 4 ) and sulfate (SO 4 ) concentrations were not affected by carbamazepine (Table 4 ). However, sulfate concentrations were~20% higher, though not significantly, in the 2000 ng/L carbamazepine treatment.
Structural equation modeling results
Structural equation models (SEMs) identified several significant casual relationships between carbamazepine and the freshwater ecosystem with a significant fit to the covariance matrix (Fig. 6C) . However, the initial and intermediate models ( Fig. 6A and B) did not account for a significant proportion of variability in the abiotic components of the ecosystem (r b 0.05) and did not have a significant fit to the covariance matrix and therefore were rejected in favor of the final SEM. The final SEM identified several significant causal relationships between carbamazepine and the biotic and abiotic characteristics of the mesocosms (Fig. 6C ) with a significant fit to the covariance matrix (χ 2 = 8.126, df = 14, P = 0.883). Significant pathways included the effects of carbamazepine on sediment organic matter (standardized path coefficient = −0.47); the effects of copepod abundance and the effects of Elimia and Helisoma standing biomass on nitrate concentrations (0.87, −0.33 and −0.45, respectively); the effects of Helisoma standing biomass on phosphate concentrations (−0.91); and the effects of percent organic matter in sediment on cladoceran abundance (0.72). However, the pathways linking carbamazepine to cladoceran abundance (− 0.07) and Helisoma standing biomass (−0.3) were not significant. Additionally, the pathway linking Elimia standing biomass to algal mass (0.13) was not significant. The model accounted for a substantial portion of the variation in algal mass (r = 0.56), sediment percent organic matter (r = 0.63) and concentrations of nitrate (r = 0.65) and phosphate (r = 0.58), therefore providing insight into how environmentally relevant concentrations of carbamazepine affect freshwater ecosystems. Because structural equation models look at multiple variables simultaneously, subtle links among interacting factors can be identified. For example, univariate analyses did not identify significant effects of carbamazepine on nutrients directly; but, our SEM model indicates that carbamazepine indirectly affects nutrient concentrations, potentially through microbial activity.
Discussion
Results from this mesocosm experiment indicate that environmentally relevant concentrations of carbamazepine influenced pond community structure, biodiversity, and ecosystem dynamics. Ecosystem processes were altered in the presence of carbamazepine as hypothesized (McMahon et al., 2012) . However, contrary to our predictions, carbamazepine induced an increase in diversity. Research focused on other freshwater pollutants suggests that biodiversity declines in the presence of anthropogenic stressors (Muñoz et al., 2009; Vörösmarty et al., 2010; McMahon et al., 2012; Beketov et al., 2013) , though the modes of action and mechanisms driving these patterns are not well understood. However, this inconsistency can be understood given that environmentally relevant concentrations of carbamazepine are not likely acutely toxic to freshwater organisms (Oetken et al., 2005; Dussault Table 3 Mean standing biomass (mg dry mass/31 d) of all four taxa of gastropods across CBZ treatments. Standard deviations in parentheses. There were no significant differences in standing biomass of any taxa between treatments and control (P N 0.05).
CBZ (ng/L)
Physa Lymnaea Elimia Helisoma
Water control 5.7 (5.9) 0.6 (1. Nieto et al., 2013) . Despite limited toxicity, freshwater organisms exposed to carbamazepine experience sub-lethal effects, which appeared to alter the community structure. These alterations may have led to an increase in biodiversity through community interactions such as competition and changed ecosystem dynamics (Fig. 6) . Sub-lethal effects, such as changes in behavior (De Lange et al., 2006 ) development (Nentwig et al., 2004; Oetken et al., 2005) , mating success (Lürling et al., 2006) and immune response (Martin-Diaz et al., 2009; Gust et al., 2013; Gillis et al., 2014) , have been observed after exposure to carbamazepine. For instance, Gust et al. (2013) demonstrated that mixtures of psychiatric drugs, consisting of venlafaxine (200 ng/L), carbamazepine (200 ng/L) and diazepam (10 ng/L), influenced the immune response of pond snails (L. stagnalis). While this mixture of pharmaceuticals did not impair immune-competence, significant changes in gene expression were observed in which Toll-like receptor (TLR4), heat-shock proteins (HSP70) and selenium-dependent glutathione peroxidase (Se-GPx) were up-regulated and allograft inflammatory factor-1 (AIF-1), catalase (CAT) and glutathione reductase (GR) were down-regulated. Additionally, Lamichhane et al. (2013) found that Ceriodaphnia dubia exposed to carbamazepine experienced decreased fecundity at 196.7 μg/L in the F0 and F1 generations and decreased adult body length at 264.6 μg/L in the F2 generation. In the present study, D. pulex abundance declined in carbamazepine treatments (Fig. 4) though behavior was not measured and thus the specific mechanism resulting in declines is unclear. Other sub-lethal effects, changes in life history, may have caused this decline (Cleuvers, 2003; Lamichhane et al., 2013) as it is not likely that the carbamazepine treatments were acutely toxic to D. pulex (LC50 N 100 mg/L; Han et al., 2006) . Lürling et al. (2006) found negative effects of similar carbamazepine concentrations on D. pulex growth, morphology, and population growth rates. Similar studies focused on pesticides have observed an increase in zooplankton diversity due to declines in Daphnia abundance; an organism that commonly depresses populations of small zooplankton taxa (Hanazato, 1994) . Therefore, changes in community structure potentially brought about by sub-lethal effects and the decline in D. pulex abundance may explain the observed increase in invertebrate diversity.
Changes in diversity and species composition can profoundly alter ecosystem dynamics (Chapin et al., 1997; Hooper and Vitousek, 1997; Tilman et al., 1997; Downing and Leibold, 2002; Cardinale et al., 2002; Steiner et al., 2005; Wojdak, 2005; Hooper et al., 2012) . Downing and Leibold (2002) utilized a mesocosm experiment to demonstrate the importance of both species richness and composition to productivity, respiration and decomposition in freshwater ecosystems. Additionally, McMahon et al. (2012) showed that declines in species richness induced by exposure to chlorothalonil reduced decomposition and water clarity and elevated primary production and dissolved oxygen in a mesocosm experiment. Further, zooplankton diversity can be critical to the algal community with high zooplankton diversity resulting in an increase in large, grazer resistant algae (N 35 μm chlorophyll a; Steiner et al., 2005) . In this study, carbamazepine increased Elimia and decreased Helisoma standing biomass, increased invertebrate diversity and decreased D. pulex abundance, which in turn affected ecosystem characteristics such as dissolved nutrient concentrations, primary production and decomposition.
Carbamazepine did not influence biomass or standing biomass of Physa or Lymnaea. Both taxa exhibited changes in biomass likely due to seasonal variability, not from exposure to carbamazepine (Brown, 2001) . However, carbamazepine influenced biomass measurements of Elimia and Helisoma. Across treatments, Elimia lost biomass over the course of the experiment; however, biomass loss was less in the carbamazepine treatments. Helisoma biomass increased over the course of the experiment but this increase was lower in the carbamazepine treatments. Additionally, the SEM indicated the potential direct effect of carbamazepine on the standing biomass of Helisoma and indirect effect of carbamazepine on Elimia standing biomass. Exposure to carbamazepine may have induced physiological stress in Helisoma and affected interspecific competition between Elimia and Helisoma (Brown, 2001 ; -Diaz et al., 2009; Gust et al., 2013; Gillis et al., 2014) though these variables were not measured in this study. Other studies suggest that the influence of anthropogenic pollutants on freshwater organisms may depend on the relative strength of interspecific competition (Wojdak, 2005; Liess et al., 2013; Dolciotti et al., 2014) . Pleurocerids (i.e., Elimia) are better competitors when compared to pulmonates (i.e. Helisoma; Brown et al., 1998) . Therefore, exposure to carbamazepine may have negatively influenced the immune-competence of Helisoma and further impaired the competitive ability of this taxon and hindered any potential recovery, leading higher standing biomass of Elimia and decreased biomass loss in carbamazepine treatments.
Martin
Carbamazepine altered the community structure by reducing the abundance of cladocerans and increasing ostracod and copepod abundance. This shift in the zooplankton community may have been influenced by the abundance of D. pulex. Daphnia depresses population growth of small zooplankton taxa through competition (Hanazato, 1994 (Hanazato, , 2001 . Exposure to carbamazepine potentially reduced the abundance of D. pulex, which may have increased the abundance of copepods and small cladocerans (Fig. 4) . Moreover, the SEM suggests that carbamazepine had indirect effects on cladoceran abundance through sediment organic matter and indirect effects on copepod abundance through a reduction in cladocerans. The observed shift to copepod dominance is similar to other studies focused on anthropogenic pollutants (Havens, 1994; Relyea, 2005) . Relyea (2005) observed a decrease in cladoceran and an increase in copepod abundance after exposure to insecticides in a mesocosm experiment. The effects of carbamazepine on the zooplankton community may also be explained by alterations in food resource availability within the mesocosm (Smith, 2001) . Carbamazepine reduced the abundance of D. pulex and sediment organic matter but had no effect on algae, which may have also affected changes in the zooplankton community toward copepod dominance.
Carbamazepine influence on ecosystem dynamics
Environmentally relevant concentrations of carbamazepine negatively affected sediment organic matter. It is well established that sediment organic matter is a critical characteristic governing microbial activity in freshwater (Palmer et al., 2000) . Thus, carbamazepine may have influenced microbial activity as well as invertebrate activity affecting decomposition rates (Ferrari et al., 2003; McMahon et al., 2012) . Decomposition of organic matter is a main source of energy in aquatic habitats and alterations in decomposition can have profound effects on freshwater ecosystems (Covich et al., 1999; Palmer et al., 2000) .
In contrast, carbamazepine did not directly influence primary production. Zhang et al. (2012) found that carbamazepine could inhibit growth of Scenedesmus obliguus and Chlorella pyrenoidosa. However, the effective concentrations (EC50) were orders of magnitude higher than those found in surface waters (EC50 N 0.8 and 7 mg/L; respectively) and assessed in this study. At environmentally relevant concentrations, carbamazepine may be more likely to have indirect effects on primary production through changes in the invertebrate community. The dominance of copepods in the zooplankton community may explain the observed changes in algal and phytoplankton biomass. Copepods typically do not consume the smallest primary producers, which are commonly ingested by cladocerans (Smith, 2001) . Therefore, phytoplankton biomass may increase and algal mass may decrease over prolonged periods of carbamazepine exposure. While a small increase in phytoplankton biomass was observed in this experiment, there was no relationship to carbamazepine exposure. Future research should be conducted to quantify potential effects on primary production. The SEM indicated that carbamazepine influenced nitrate and phosphate concentrations through alterations in the invertebrate community. Specifically, carbamazepine's effects on copepod abundance and standing biomass of Elimia and Helisoma influenced nitrate and phosphate concentrations; therefore this pharmaceutical pollutant may have indirectly altered nutrient cycling. Aquatic invertebrates, particularity those that bioturbate sediments, alter the flux of nutrients in water (Covich et al., 1999; Palmer et al., 2000) . Changes in nutrient concentrations may lead to changes in the efficiency of energy transfer through food chains (Dickman et al., 2008) . Additionally, changes in nutrient concentrations may influence other ecosystem functions such as primary production and decomposition, as identified in this study (Palmer et al., 2000) which may subsequently affect higher trophic level organisms.
Conclusion
Despite the ubiquity of carbamazepine in surface waters, previous studies have not adequately addressed how chronic exposure at environmentally relevant concentrations may influence freshwater ecosystems (Rosi-Marshall and Royer, 2012; Hughes et al., 2013) . Results from this in situ mesocosm experiment demonstrate how environmentally relevant concentrations of carbamazepine alter the communities and processes of freshwater ecosystems. The SEM illustrates that carbamazepine altered the biomass of gastropods and shifted zooplankton abundances to favor copepods. These changes affected primary production and decomposition. Additionally, multivariate analyses indicated that carbamazepine altered dissolved nutrient concentrations, which along with the decline in D. pulex abundance potentially influenced the transfer of energy through food chains (Dodson and Hanazato, 1995; Hanazato, 2001; Dickman et al., 2008) . Importantly, structural equation modeling identified potential indirect effects of carbamazepine on freshwater communities and ecosystems not identified with univariate analyses. More research is needed to fully understand how carbamazepine affects freshwater ecosystems. Specifically, additional research should be conducted to determine how ecosystem dynamics (i.e., decomposition and primary production) respond to carbamazepine exposure. Furthermore, future research should integrate ecological principles into ecotoxicology experiments to develop mechanisms on how carbamazepine influences population dynamics (i.e., intra-and interspecific competition and predation) and ecosystem processes (Relyea and Hoverman, 2006; Clements and Rohr, 2009 ).
